Location History:
- Ibaragi-ken, JP (2003)
- Ibaragi, JP (2004)
- Ibaraki, JP (2013)
Company Filing History:
Years Active: 2003-2013
Title: Yasuyuki Kuroiwa: Innovator in Hematopoietic Stem Cell Research
Introduction
Yasuyuki Kuroiwa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of hematopoietic stem cell research, holding a total of 3 patents. His work focuses on methods that enhance the survival and efficacy of transplanted stem cells, which are crucial for various medical therapies.
Latest Patents
Kuroiwa's latest patents include a method for producing a composition that promotes the survival of transplanted hematopoietic stem cells. This innovative method involves the proliferation and activation of HLA matched lymphocytes from mononuclear cells separated from peripheral blood or umbilical cord blood. The resulting composition is designed to prevent survival failure of transplanted hematopoietic stem cells and to promote their survival in patients. The administration of this composition can vary based on the patient's age and condition, with a recommended dosage of a humanized antibody ranging from 0.2 to 20 ml/kg/day.
Another significant patent involves the use of cord blood-derived activated lymphocytes, which have shown effectiveness in preventing and treating various tumors and infections. This method includes the preparation of lymphocytes derived from cord blood, which can be proliferated in vitro. These activated lymphocytes are also effective in preventing disease recurrence and promoting the take of stem cells or other organs.
Career Highlights
Throughout his career, Kuroiwa has worked with several companies, including Humantec Ltd. and Lymphotec Inc. His innovative approaches and research have positioned him as a key figure in the field of stem cell therapy.
Collaborations
Kuroiwa has collaborated with notable individuals in his field, including Kenzo Bamba and Teruaki Sekine. These collaborations have further advanced his research and contributed to the development of effective therapies.
Conclusion
Yasuyuki Kuroiwa's contributions to hematopoietic stem cell research are invaluable. His innovative patents and collaborative efforts continue to impact the medical field positively.